| scholarly article | Q13442814 |
| P2093 | author name string | Jun Chen | |
| Richard L Ehman | |||
| Rohit Loomba | |||
| Saumya Jayakumar | |||
| Meng Yin | |||
| Claude B Sirlin | |||
| Mark A Valasek | |||
| Jonathan Hooker | |||
| David Brenner | |||
| Carolyn Hernandez | |||
| Lisa Richards | |||
| Ricki Bettencourt | |||
| Edward R Cachay | |||
| Phirum Nguyen | |||
| Emily Rizo | |||
| Ethan Sy | |||
| Cyrielle Caussy | |||
| Mosab H Alquiraish | |||
| Sandra Cepin | |||
| Lynda Fortney | |||
| P2860 | cites work | Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease | Q82648058 |
| Liver biopsy | Q83395480 | ||
| Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 | ||
| Magnetic resonance elastography of liver: technique, analysis, and clinical applications | Q27027849 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis | Q30238749 | ||
| Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity. | Q30357814 | ||
| Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations | Q30395051 | ||
| Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study | Q30418856 | ||
| Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Q35893923 | ||
| Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease | Q36014015 | ||
| Non-invasive evaluation of liver fibrosis using transient elastography | Q37107626 | ||
| Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | Q38680300 | ||
| American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases | Q39262015 | ||
| Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease | Q40444861 | ||
| Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. | Q41042091 | ||
| Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up | Q42201783 | ||
| Magnetic resonance elastography for the noninvasive staging of liver fibrosis. | Q46601756 | ||
| EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral? | Q50666991 | ||
| Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients | Q57735452 | ||
| Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease | Q58622754 | ||
| Sampling variability of transient elastography according to probe location. | Q64957181 | ||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-11-02 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease |
| Q64104335 | A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease |
| Q100467634 | Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity |
| Q91443339 | Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension |
| Q89123381 | Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants |
| Q100994722 | Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q53703261 | Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis. |
| Q46476704 | Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions |
Search more.